4.1 Article

Bioavailability Considerations in Evaluating Drug-Drug Interactions Using the Population Pharmacokinetic Approach

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

The Simcyp® Population-based ADME Simulator

Masoud Jamei et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)

Article Pharmacology & Pharmacy

Quantitative Evaluation of Pharmacokinetic Inhibition of CYP3A Substrates by Ketoconazole: A Simulation Study

Ping Zhao et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2009)

Review Biotechnology & Applied Microbiology

Simulation and prediction of in vivo drug metabolism in human populations from in vitro data

Amin Rostami-Hodjegan et al.

NATURE REVIEWS DRUG DISCOVERY (2007)

Article Pharmacology & Pharmacy

Drug interaction studies: Study design, data analysis, and implications for dosing and labeling

S-M Huang et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)

Article Pharmacology & Pharmacy

Stochastic prediction of CYP3A-mediated inhibition of midazolam clearance by ketoconazole

Jenny Y. Chien et al.

DRUG METABOLISM AND DISPOSITION (2006)

Article Medicine, Research & Experimental

Scientific perspectives on drug transporters and their role in drug interactions

Lei Zhang et al.

MOLECULAR PHARMACEUTICS (2006)

Article Pharmacology & Pharmacy

Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice

ML Veronese et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2003)

Article Pharmacology & Pharmacy

Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping

JI Lee et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)